Información del artículo
Resumen
Tratamos de conocer la seroprevalencia de anticuerpos anti PVB19 en un grupo de 353 donantes de Madrid.
La investigación de anticuerpos IgG se realizó mediante ELISA.
Se detectaron 162 casos positivos, 89 en mujeres (48,9%) y 73 en varones (42,7%), y en ambos casos la prevalencia de anticuerpos frente al PVB19 se incrementó con la edad.
Summary
We aim to know the seroprevalence of antibodies to human parvovirus B19 (PVB19) in a group of 353 donors in Madrid.
Antibodies of the inmunoglobulin G (IgG) were investigated using a commercial ELISA system.
Were detected 162 positive cases, including 89 females (48,9%) and 73 males (42,7%). The prevalence of antibodies against PVB19 increased with age in both groups.
El Texto completo está disponible en PDF
Bibliografía
[1.]
MJ Anderson, SEyt Jones, SP Fisher-Hoch, E Lewis, SM May, CLR Bartlett, et al.
Human parvovirus, the cause of erythema infectiosum (fifth disease)?.
Lancet, 1 (1983), pp. 1378
[2.]
LJ. Anderson.
Human parvovirus B19.
Clinical Virology, pp. 613-631
[3.]
T Brown, A Anand, LD Ritchie, JP Clewley, TMS. Reid.
Intrauterine parvovirus infection associated with hydrops fetalis.
Lancet, 2 (1984), pp. 1033
[4.]
BO Corsi, A Azzi, M Morfini, R Fanci, RP. Ferrini.
Human parvovirus infection in haemophiliacs first infused with treated clotting factor concetrates.
J Med Virol, 25 (1988), pp. 165-170
[5.]
M Tsujimura, K Matsushita, H Shiraki, H Sato, K Okochi, Y. Maeda.
Human parvovirus B19 infection in blood donors.
Vox Sang, 69 (1995), pp. 206-212
[6.]
H Rollag, G Patou, JR Pattison, M Degre, SA Evensen, SS Froland, et al.
Prevalence of antibodies against parvovirus B19 in Norwegians with congenital coagulation factor defects treated with plasma products from small donors pool.
Scand J Infect Dis, 23 (1991), pp. 675-679
[7.]
S Wiersbitzky, TF Schwarz, R Bruns, G Jager, S Bittner, H Weidemann, et al.
Seroprevalence of human parvovirus B19 antibodies (Sticker’s disease/erytema infectiosum) in the DRG population.
Kinderarztl Prax, 58 (1990), pp. 185-189
[8.]
Y Poovorawan, A Theamboonlers, P Suandork, P. Hirsch.
Prevalence of antibodies to parvovirus B19 in Thailand.
J Trop Med Public Health, 31 (2000), pp. 422-424
[9.]
K yllensten, A Sönnerborg, C Jorup-Rönström, M Halavarsson, Z. Yun.
Parvovirus B19 infection in HIV-1 infected patients with.
anemia. fection, 22 (1994), pp. 356-358
[10.]
BO Corsi, A Azzi, M Morfini, R Fanci, RP. Ferrini.
Human parvovirus infection in haemophiliacs first infused with treated clotting factor concentrates.
J Med Virol, 25 (1988), pp. 165-170
[11.]
S Muñoz, A Alonso, MJ Fernández, JL Muñoz, Rodríguez M. García.
Seroprevalencia frente a parvovirus B19 en donantes de sangre.
Enferm Infecc Microbiol Clin, 16 (1998), pp. 161-162
[12.]
Rebon M Mata, Husson C Bartolomé, Hermida I. Bernárdez.
Seroprevalencia de anticuerpos antiparvovirus en una muestra de donantes de sangre en Galicia.
Enferm Infect Microbiol Clin, 16 (1998), pp. 25-27
Copyright © 2002. Elsevier España, S.L.. Todos los derechos reservados
